Xambo, 80 boxes of bulk capsules. Each containing 12,053 capsules in each box.
Recalling firm: West Coast Laboratories Inc
Why it was recalled
West Coast Laboratories is recalling Xambo and Devagrass because there may be presence of 1,3-dimethylamylamine (DMAA).
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Mar 20, 2017.
Check your package
Compare the exact product and package details with the label you have.
ProductXambo, 80 boxes of bulk capsules. Each containing 12,053 capsules in each box.
FDA code information
361215
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Xambo, 80 boxes of bulk capsules. Each containing 12,053 capsules in each box.
Original FDA recall reason
West Coast Laboratories is recalling Xambo and Devagrass because there may be presence of 1,3-dimethylamylamine (DMAA).
Recall details
- Recall number
- F-1430-2017
- Event ID
- 76003
- FDA status
- Terminated
- Initiated
- Jan 11, 2017
- Reported
- Feb 8, 2017
- Classified
- Feb 1, 2017
- Terminated
- Mar 20, 2017
- Quantity
- 964,240 capsules
- Location
- Gardena, CA, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Letter
Where it was distributed
Colombia, South America
FDA source record · F-1430-2017
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.